Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

The Therapeutic Effect of Electroconvulsive Therapy on Depressive Patients of Different Ages: A Systematic Review and Meta-Analysis

AI Summary
  • Electroconvulsive therapy significantly reduces depressive symptom severity across age groups, shown by decreased HAMD and MADRS scores.
  • Patients older than 60 years show greater improvement in depressive symptoms and WMS recognition memory after ECT compared with younger cohorts.
  • ECT increases global cognition measured by MMSE, but produces no significant effects on individual Wechsler Memory Scale subtests.
Summarise with AI (MRCPsych/FRANZCP)

Depress Anxiety. 2026 Aug 29;2026:4345722. doi: 10.1155/da/4345722. eCollection 2026.

ABSTRACT

BACKGROUND: Major depressive disorder (MDD) has become one of the diseases that seriously affects the quality of life and social function of patients. Electroconvulsive therapy (ECT) is an important method for treating mental disorders. This study aims to conduct a comparison of symptomatic improvement in patients with MDD across different age groups following ECT, thereby providing more precise and personalized treatment plans.

METHODS: PubMed, Cochrane Library, CNKI, Wanfang, and other databases were searched for related studies from self-built databases until February 2025. The retrieved studies were then subjected to a meta-analysis using R software. Based on the assessment of heterogeneity across studies, either a fixed-effect model or a random-effect model was selected for data synthesis.

RESULTS: A total of 15 eligible articles were included in this meta-analysis, involving 1617 patients with MDD. The results indicated ECT could reduce the scores of the Hamilton Depression Rating Scale (HAMD), Montgomery-Åsberg Depression Rating Scale (MADRS), and Hamilton Anxiety Rating Scale (HAMA). Additionally, it could increase the scores of the Mini-Mental State Examination (MMSE). However, no statistical significance was observed on the subscales of the Wechsler Memory Scale (WMS). Subgroup analysis and meta-regression revealed that the older patients (>60 years old) may benefit more significantly in improving depressive symptoms (HAMD and MADRS) and WMS recognition memory. No significant age-related differences are observed in HAMA, MMSE, or other WMS subtests.

CONCLUSIONS: ECT demonstrates therapeutic effects across all age groups of patients with MDD. The older group seemed to benefit more from this treatment modality compared to other age groups. These findings contribute to a better understanding of the differential effects of ECT in patients with MDD of different ages, which may guide clinical decision-making.

PMID:42668924 | PMC:PMC13525544 | DOI:10.1155/da/4345722

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD